Reduction of L-type amino acid transporter 1 mRNA expression in brain capillaries in a mouse model of Parkinson's disease

Medicine & Life Sciences

• Amino Acid Transport Systems 100%
• Blood-Brain Barrier 71%
• Capillaries 71%
• Parkinson Disease 61%
• 4-phenyl-1,2,3,6-tetrahydropyridine 43%
• Messenger RNA 41%
• Brain 36%
• Levodopa 32%
• creatine transporter 25%
• taurine transporter 25%
• Organic Cation Transporter 2 24%
• Neutral Amino Acids 21%
• Norepinephrine Plasma Membrane Transport Proteins 21%
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine 18%
• Serotonin Plasma Membrane Transport Proteins 18%
• Dopamine Plasma Membrane Transport Proteins 18%
• Facilitative Glucose Transport Proteins 17%
• Dopaminergic Neurons 15%
• Tyrosine 13%
• Amino Acids 10%
• Drug Therapy 8%
• Therapeutics 7%
• Pharmaceutical Preparations 6%

Chemical Compounds

• Reduction 33%
• Acid 25%
• 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 19%
• Creatine 15%
• Taurine 15%
• Organic Cation 14%
• Serotonin 13%
• Drug 12%
• Dopamine 11%
• Tyrosine 11%
• Glucose 9%